title: The aged rat model of ovarian hormone deficiency bone loss.
abstract: Three studies were carried out. First, the effects of aging on the maturation of the female skeleton were assessed. Second, the hypothesis that has linked ovarian hormone deficiency bone loss to hypercalcemic suppression of the parathyroids leading to a decrease in 1,25-dihydroxyvitamin D synthesis and gut absorption of calcium was examined. Third, the effects of ovariectomy and a combination of ovarian hormone deficiency and low dietary calcium on bone and the calcium-regulating hormones were evaluated. After 6 months, ovariectomy and a low calcium diet independently decreased the density of the ilium, the femur, and the fourth lumbar vertebra as well as the calcium content of the latter two. The effects of the two treatment regimens were additive and more marked in the vertebral bone. Ovariectomy lowered serum calcitonin only in animals fed a normal diet and had no effect on serum PTH and vitamin D metabolites, while a low calcium diet caused a significant increase in serum 1,25-dihydroxyvitamin D. In both dietary regimens ovariectomy resulted in about a 30% decrease in intestinal calcium absorption. A low calcium diet increased morphometric indices of bone formation and bone resorption as did ovariectomy, with resorption exceeding formation. The discussion of our findings led to the conclusion that the aged rat model of ovarian hormone deficiency bone loss qualifies for serious consideration as a practical convenient cost-effective animal model for exploring aspects of the pathogenesis and treatment of postmenopausal bone loss.
authors.affiliation: Department of Physiology, University of Texas Health Science Center, San Antonio 78284.
authors.forename: D N
authors.initials: DN
authors.lastname: Kalu
authors.forename: C C
authors.initials: CC
authors.lastname: Liu
authors.forename: R R
authors.initials: RR
authors.lastname: Hardin
authors.forename: B W
authors.initials: BW
authors.lastname: Hollis
mesh_terms: D000375:Aging / Q000502:physiology*; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001846:Bone Development; D001862:Bone Resorption; D001842:Bone and Bones / Q000473:pathology / Q000503:physiopathology; D002116:Calcitonin / Q000097:blood; D002117:Calcitriol / Q000378:metabolism; D002118:Calcium / Q000008:administration & dosage / Q000378:metabolism; D004195:Disease Models, Animal; D004958:Estradiol / Q000097:blood; D005260:Female; D007408:Intestinal Absorption; D010024:Osteoporosis / Q000473:pathology / Q000503:physiopathology; D010052:Ovariectomy; D010053:Ovary / Q000503:physiopathology*; D010280:Parathyroid Glands / Q000503:physiopathology; D010281:Parathyroid Hormone / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D012709:Serum Albumin / Q000378:metabolism
chemical_list: D010281:Parathyroid Hormone; D012709:Serum Albumin; D004958:Estradiol; D002116:Calcitonin; D000469:Alkaline Phosphatase; D002117:Calcitriol; D002118:Calcium